Jaguar Health (JAGX) Work In Process (2018 - 2026)
Jaguar Health's (JAGX) quarterly Work In Process came in at $6.9 million in Q1 2026, down 10.6% year-on-year from $7.7 million in Q1 2025, and down 4.56% on a QoQ basis from $7.2 million in Q4 2025.
Jaguar Health (JAGX) Work In Process (2018 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 9 years of Work In Process data on file, last reported at $6.9 million in Q1 2026.
- On a quarterly basis, Work In Process fell 10.6% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 10.6% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, down 2.31% from the prior year.
- Work In Process for Q1 2026 stood at $6.9 million, down from $7.2 million in the prior quarter.
- Over the last five years, Work In Process for JAGX reached as high as $7.7 million in Q1 2025 and fell as low as $2.4 million in Q1 2022.
- Historically, Work In Process has averaged $5.8 million across 5 years, with a median of $6.5 million in 2023.
- Across the five-year window, Work In Process surged 122.25% in 2023 and fell 10.6% in 2026, its largest moves.
- Year by year, Work In Process stood at $3.6 million in 2022, then surged by 81.08% to $6.5 million in 2023, then gained by 13.66% to $7.4 million in 2024, then slipped by 2.31% to $7.2 million in 2025, then fell by 4.56% to $6.9 million in 2026.
- Per Business Quant data, the three most recent Work In Process figures were $6.9 million in Q1 2026, $7.2 million in Q4 2025, and $7.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.61 Mn |
| Mar 31, 2025 | 7.73 Mn |
| Dec 31, 2024 | 7.41 Mn |
| Sep 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | 6.83 Mn |
| Mar 31, 2024 | 6.13 Mn |
| Dec 31, 2023 | 6.52 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 5.38 Mn |
| Dec 31, 2022 | 3.60 Mn |
| Sep 30, 2022 | 3.06 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 2.76 Mn |
| Sep 30, 2021 | 2.20 Mn |
| Jun 30, 2021 | 1.71 Mn |